COMMENT

THE development of a Covid vaccine by the end of 2020 is possible but remains our most optimistic prediction.

We have to wait for the results of the vaccines currently in clinical trials to know whether they are effective.

Even then, we are unlikely to have a fully protective vaccine for some time.

There are reasons to be cautiously optimistic, but it is very hard to say at this stage until we have the data from the trials.

We have been open about the fact developing a vaccine is a complex process which could take many months and has no guarantees.

Developing one has been an urgent priority for us since the Vaccine Taskforce was established. We’re working hand in hand with the life sciences industry to help find a successful vaccine for Covid- 19, supporting their research and encouraging innovation to benefit patients.

There have been unprecedented levels of collaboration between academia, industry, regulators and the Government in our efforts. Alongside the acceleration of development, the Vaccine Taskforce is ensuring the country’s manufacturing capabilities are scaled up.

So if a vaccine is found and is effective it can be made available to the public as quickly as possible.

The NHS has a tried and tested track record for delivering vaccination programmes.

It will work with existing partners across the healthcare system to ensure a Covid- 19 vaccine can be deployed safely and effectively.

The Vaccine Taskforce will continue to work with academics and industry to support our ambition to develop and distribute an effective vaccine as soon as possible.